|
The House Committee on Energy and Commerce
July 10, 2003
The Honorable Elias Zerhouni, M.D.
Director
National Institutes of Health
9000 Rockville Pike
Bethesda, MD 20892
Dear Dr. Zerhouni:
We are writing in furtherance of the Committee's investigations into
continuing management concerns and alleged financial waste and abuse at the
National Institutes of Health (NIH). On June 26, 2003, CBS Evening News aired a
story about Dr. Edward McSweegan, a NIH microbiologist, who alleges that he has
no true tasks or responsibilities in his current position reflective of the
estimated $100,000 annual salary he receives. He claims that he was removed from
his position as NIH's program officer for Lyme disease in June 1995 due to his
criticism of a Lyme disease support group, and subsequently lost control over
all the grants that he administered. The Washington Post also reported the story
on July 4, 2003.
Dr. McSweegan claims that he is paid to perform tasks that one would
ordinarily delegate to an intern, such as arranging coffee for lunches and
forwarding messages. However, the NIH reportedly states that Dr. McSweegan is
the Director of the U.S.-Indo Vaccine Action Program, and in this capacity
traveled outside of the country representing the agency. This title is
apparently news to Dr. McSweegan, who says that he was not aware it. The NIH
states he produced reports and other work products in this position. According
to Dr. McSweegan, he struggles to fill his eight-hour workdays by reading,
exercising and writing fiction.
Based on these reports, and the Committee's continuing interest in concerns
about whether NIH is wisely managing both its employees and its increased
financial resources, we are initiating an examination of the allegations made by
Dr. McSweegan and broader issues arising possibly from his allegations. Pursuant
to Rules X and XI or the U.S. House of Representatives, please provide the
following information by July 24, 2003:
-
All personnel records relating to Dr. McSweegan
including but not limited to employment reviews, disciplinary proceedings,
salary reviews and travel-related paperwork.
-
All records relating to Dr. McSweegan's removal
from the position of Program Officer for Lyme disease.
-
All records relating to any and all positions
held by Dr. McSweegan after leaving the position of program officer for Lyme
disease, including but not limited to the mission statement, daily
responsibilities, direct reports, salary, GS levels, evaluations and his
immediate supervisor in each position.
-
All records relating to all of Dr. McSweegan's
job-related travel in his current position as U.S.-Indo Vaccine Action
Program, including but not limited to any documents regarding the
justification for the travel, itineraries, who financed the travel, reports
or memoranda generated as a result of the travel, and any follow-up done on
the issues that were the justification for the travel.
-
A matrix of all NIH scientists or
administrative officer employees who have been transferred from an NIH
intramural program to an NIH extramural program, and NIH officials who have
administered research grants and had all those grants transferred to other
employees. The matrix should cover the period from January 1, 1998 to the
present. Include in the matrix the employee's name, job titles, dates of
participation, description of projects, qualifications for participation in
each project and reason for the transfer.
We also request that you share this letter with all NIH employees to ensure
that they are aware of this Committee's interest in these particular allegations
and to provide them with contact information for our staff if any NIH employee
wishes to make allegations similar to those of Dr. McSweegan.
Please note that, for the purpose of responding to these requests, the terms
"records" and "relating" should be interpreted in accordance
with the attachment to this letter. In addition, we are requesting that
following production of the records to the Committee, you make available NIH
employees for Committee staff interviews as requested by Committee staff.
Thank you for your assistance. If you have any questions, please contact Ann
Washington of the Majority Committee staff at (202) 226-2424.
Sincerely,
W.J. "Billy" Tauzin
Chairman
James C. Greenwood
Chairman, Subcommittee on Oversight and Investigations
cc:
John D. Dingell, Ranking Member
Peter Deutsch, Ranking Member, Subcommittee on Oversight and Investigations
# # #
Related
Documents
Printer
Friendly
Comment
On This Page
Related
Documents
|